Herpes Zoster Infections News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Merck & Co.'s Human Vaccines Business in 3Q17 - Market Realist



Market Realist
 
Merck & Co.'s Human Vaccines Business in 3Q17 
Market Realist
Other human vaccines. In addition to Gardasil, Merck's human vaccines portfolio also includes ProQuad/Varivax, RotaTeq, Pneumovax 23, and Zostavax. Total revenues for the human vaccines portfolio decreased 3% to ~$1.8 billion in 3Q17 compared to $1.9 ...
Merck & Company, Inc. (MRK) Zacks.com
X0306 4 2017-11-08 0000310158 Merck & Co., Inc. MRK 0001140799 GLOCER THOMAS H MERCK - SEC.gov SEC.gov
SEC FORM 4 - SEC.gov SEC.gov
SEC.gov 
all 124 news articles » 


Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine - Infectious Disease Advisor



Infectious Disease Advisor
 
Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine 
Infectious Disease Advisor
The new adjuvanted herpes zoster subunit vaccine (HZ/su) would cost less and offer good value compared with the current live attenuated herpes zoster vaccine (ZVL), according to a cost-effectiveness study published in JAMA Internal Medicine.1 ...

 


Herpes Zoster Vaccination Reduce Shingles Outbreaks by 35% - PrecisionVaccinations (press release)



PrecisionVaccinations (press release)
 
Herpes Zoster Vaccination Reduce Shingles Outbreaks by 35% 
PrecisionVaccinations (press release)
Since 2006, a live attenuated herpes zoster vaccine, Zostavax ( Merck), has been indicated by PHE for use in immunocompetent adults aged 50 years and older. The vaccine contains the same antigen (Oka strain of varicella zoster virus) as the childhood ...

 


No Difference in Herpes Zoster Risk With Biologic- vs Nonbiologic-Treated Psoriasis - Infectious Disease Advisor



Infectious Disease Advisor
 
No Difference in Herpes Zoster Risk With Biologic- vs Nonbiologic-Treated Psoriasis 
Infectious Disease Advisor
HealthDay News ? For patients with psoriasis, the risk of herpes zoster (HZ) is not significantly increased for systemically treated patients or for those receiving biologics vs nonbiologics, according to a research letter published in JAMA ...

 


Why a New Vaccine for Preventing Shingles Received FDA Approval and a CDC Recommendation - LWW Journals



Why a New Vaccine for Preventing Shingles Received FDA Approval and a CDC Recommendation 
LWW Journals
The recommendation from an advisory committee to the Centers for Disease Control and Prevention to approve a new vaccine for herpes zoster was close, but experts say the vaccine is a welcome treatment advance. Only days after the US Food and Drug ...

 


Herpes Zoster Infection Treatment Market to Garner Maximum ... - satPRnews (press release)



Herpes Zoster Infection Treatment Market to Garner Maximum ... 
satPRnews (press release)
Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The ...

and more » 


Can Corticosteroids and Anaesthetics Prevent Postherpetic Neuralgia? - Medical News Bulletin



Medical News Bulletin
 
Can Corticosteroids and Anaesthetics Prevent Postherpetic Neuralgia? 
Medical News Bulletin
Chickenpox is a common childhood infection caused by the herpes zoster virus. However, once the rash caused by the virus has cleared up, the virus can lay dormant for years. Later in life, or due to a compromised immune system, the virus can reactivate ...

 


Infectious Diseases AZ: New shingles vaccine should soon be available - Douglas Daily Dispatch



Infectious Diseases AZ: New shingles vaccine should soon be available 
Douglas Daily Dispatch
"In excess of 30 percent of all of us are going to develop shingles sometime in our life," says Dr. Gregory Poland, director of Mayo Clinic's Vaccine Research Group. That's why the medical community is so hopeful about a new shingles (herpes zoster ...

 


Infectious Diseases A-Z: New shingles vaccine should soon be ... - Williston Daily Herald



Williston Daily Herald
 
Infectious Diseases A-Z: New shingles vaccine should soon be ... 
Williston Daily Herald
"In excess of 30 percent of all of us are going to develop shingles sometime in our life," says Dr. Gregory Poland, director of Mayo Clinic's Vaccine Research Group. That's why the medical community is so hopeful about a new shingles (herpes zoster ...

and more » 


Untangling How Epstein-Barr Virus Infects Cells - Northwestern University NewsCenter



Northwestern University NewsCenter
 
Untangling How Epstein-Barr Virus Infects Cells 
Northwestern University NewsCenter
Others include herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV) and Kaposi sarcoma virus (KSHV). In humans, EBV infects two types of cells: B cells and epithelial cells; Epithelial cells provide a barrier to that outside ...